Daito Pharmaceutical Co.,Ltd. [4577.T]

TOKYO, Apr 22 (Pulse News Wire) – Daito Pharmaceutical Co., Ltd. (4577.T) announced progress on its share repurchase program.

The company acquired 116,800 shares for a total of ¥163,912,800 through open market purchases. The board authorized the repurchase of up to 1,000,000 shares with a maximum expenditure of ¥1,500,000,000.

The program is 100.0% complete with 1,000,000 shares acquired to date.

Share buyback

Shares

116,800 shares

Total cost

¥164M

Avg ¥1,403/share

Period

2026-04-01

Progress vs authorization

116,800 shares of 1.0M shares (11.7%)

Source: TDNet filing

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.